Rice University researchers have developed a CRISPR-based gene activation strategy that boosts mitochondrial production in damaged heart cells, improving cardiac function after heart attacks in both ...

Heart failure is a serious and widespread health condition that affects millions of people in the United States and many more around the world. It places a heavy burden on both patients and healthcare ...

You can follow a treatment plan and take medications as a doctor prescribes to manage congestive heart failure. Eat a heart-healthy diet and stay physically active to slow heart failure progression.

Diagnosing heart failure usually involves several tests. Doctors may use blood tests, imaging scans, or ultrasound of the ...

There were 928 patients with CHF (i.e., International Classification of Diseases, 9th Revision, Clinical Modification codes 428, 402.01, 402.11,402.91, and 404) admitted to our institution between ...

You can follow a treatment plan and take medications as a doctor prescribes to manage congestive heart failure. Eat a heart-healthy diet and stay physically active to slow heart failure progression.

A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among high-risk cancer patients undergoing chemotherapy treatment using anthracyclines ...

Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalization if they stop taking heart ...

Heart failure disproportionately affects the black community, with research showing significantly higher rates compared to other populations. While various factors contribute to this disparity, ...

The connection between common medications and heart failure is a significant concern, especially in vulnerable communities like the Black population. While medications are essential for managing ...

A widely used heart failure medication called sacubitril/valsartan was associated with a lower risk of heart damage compared to placebo among high-risk cancer patients being treated with anthracycline ...